Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamuel Heath Regulatory News (HSM)

Share Price Information for Samuel Heath (HSM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 275.00
Bid: 250.00
Ask: 300.00
Change: 0.00 (0.00%)
Spread: 50.00 (20.00%)
Open: 275.00
High: 275.00
Low: 275.00
Prev. Close: 275.00
HSM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

8 Jul 2010 07:00

RNS Number : 0057P
Heath(Samuel) & Sons PLC
08 July 2010
 



HEATH (Samuel) & SONS PLC

 

8th JULY 2010

 

PRELIMINARY RESULTS FOR THE YEAR ENDED 31ST MARCH 2010

 

CHAIRMAN'S STATEMENT

 

I have pleasure in announcing a profit before taxation for the year of £336,000 (2009: £292,000) on sales of £9,529,000, 12.6% down on last year's sales of £10,897,000. Aided by favourable exchange rates, we managed to reverse the losses of the first six months despite sales remaining flat. This is a credit to all involved who adapted to the difficult trading conditions.

 

I would like to welcome Paul Turner and Martyn Whieldon, who have well earned their invitation to the Board, heading up the finance and sales departments respectively.

 

What can I say about the year ahead? The UK market is extraordinarily difficult to assess at this stage, as are the mixed signals coming out of North America. Our other traditional customers are in Europe and here there are enormous variances in performance and prospects between different countries.

 

To attempt to offset these uncertainties, we are doing our best to open up and enlarge our customer base elsewhere in the world. I am pleased to report that some success is being achieved with this. We have also embarked on other new marketing initiatives, such as our full time exhibition at the Chelsea Harbour Design Centre.

 

In spite of all of this, our budget shows that it is going to be difficult to repeat even the modest profit reported this year, although it has to be said that we are ahead of this budget at the time of this statement.

 

Our net assets remain strong amounting to £6,037,000 (2009: £6,709,000). We have in fact improved our cash position from £571,000 to £1,070,000. We therefore propose a same again final dividend of 6.25p per share, making a total of 11.75p for the year.

 

 

Sam Heath

 

Chairman

 

8 July 2010

 

 

For further information:

 

 

Samuel Heath & Sons Plc

John Park - Company Secretary

0121 772 2303

Evolution Securities Limited

0113 243 1619

Joanne Lake / Peter Steel

 

 

CONSOLIDATED INCOME STATEMENT FOR THE YEAR ENDED 31 MARCH 2010

 

Note

2010

2009

£000

£000

Continuing operations

Revenue

9,529

10,897

Cost of sales

(4,968)

(5,952)

Exceptional expenses (Redundancy payments)

-

(4,968)

(162)

(6,114)

Gross profit

4,561

4,783

Distribution costs

(2,784)

(3,036)

Administrative expenses

(1,372)

(1,504)

Operating profit

405

243

Gain on sale of financial assets

19

-

Finance income

370

593

Finance costs

(458)

(544)

Profit before taxation

336

292

Taxation

4

(104)

23

Profit for the year

232

315

Basic and diluted earnings per ordinary share

6

 9.2p

12.5p

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

2010

2009

£000

£000

Profit for year

232

315

Actuarial loss on defined benefit pension scheme

(1,162)

(1,153)

Deferred taxation on actuarial loss

325

322

Gains on available for sale financial assets

128

23

Cash flow hedges

103

(103)

Total comprehensive income for the year

(374)

(596)

 

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION AT 31 MARCH 2010

 

 

2010

£000

2009

£000

 

Non current assets

Intangible assets

172 

164 

Property, plan and equipment

2,239 

2,617 

Deferred tax asset

577 

284 

2,988 

3,065 

Current assets

Inventories

2,405 

2,654 

Trade and other receivables

1,653 

1,753 

Current tax receivable

88 

Available for sale financial assets

1,198 

770 

Cash and cash equivalents

1,070 

571 

Total current assets

6,326 

5,836 

Total assets

9,314 

8,901 

Current liabilities

Trade and other payables

(929)

(859)

Derivative financial instruments

(103)

Current tax payable

(112)

Total current liabilities

(1,041)

(962)

Non current liabilities

Pension scheme deficit

(2,061)

(1,015)

Deferred tax liability

(175)

(215)

Total non current liabilities

(2,236)

(1,230)

Total liabilities

(3,277)

(2,192)

Net assets

6,037 

6,709 

Equity

Called up share capital

254 

254 

Capital redemption reserve

109 

109 

Retained earnings

5,674 

6,346 

Equity shareholders' fund

6,037 

6,709 

 

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY FOR THE YEAR ENDED 31 MARCH 2010

 

Share

capital

Capital redemption reserve

Retained earnings

Total

Equity

£000

£000

£000

£000

Balance at 31st March 2008

254

109

7,542

7,905

Equity dividends paid

-

-

(596)

(596)

Profit for year

-

-

315

315

Premium on purchase of own shares

-

-

(4)

(4)

Other comprehensive income for the year

-

-

(911)

(911)

Balance at 31st March 2009

254

109

6,346

6,709

Equity dividends paid

-

-

(298)

(298)

Profit for year

-

-

232

232

Other comprehensive income for the year

-

-

(606)

(606)

Balance at 31st March 2010

254

109

5,674

6,037

 

 

CONSOLIDATED STATEMENT OF CASHFLOWS FOR THE YEAR ENDED 31 MARCH 2010

 

Note
2010
2009

£000

£000

Net cash inflow from operating activities

7

1,216

458

Cash flow from investing activities

Purchases of property, plant and equipment

(97)

(203)

Proceeds from sale of property, plant and equipment

21

43

Purchase of intangible assets

(111)

(164)

Purchase of available for sale financial assets

(545)

(747)

Proceeds from sale of available for sale financial assets

264

-

Interest received

49

56

Net cash outflow from investing activities

(419)

(1,015)

Net cash outflow from financing activities

Purchase of own shares

-

(4)

Equity dividends paid

5

(298)

(596)

Net cash outflow from financing activities

(298)

(600)

Increase/(decrease) in cash and cash equivalents

499

(1,157)

Cash and cash equivalents at beginning of period

571

1,728

Cash and cash equivalents at end of period

1,070

571

 

 

1 Adoption of new and revised Standards

 

The Group has adopted all of the new and revised Standards and Interpretations issued by the International Accounting Standards Board (IASB) and the International Financial Reporting Interpretations Committee (IFRIC) of the IASB that are relevant to its operations and effective for accounting periods beginning on 1st April 2007. The adoption of the following IFRSs has not impacted upon the financial statements:

 

IFRIC 10 - Interim Financial Reporting and Impairment

 

At the date of authorisation of these financial statements, the following Standards and Interpretations which have not been applied in these financial statements were in issue but not yet effective:

 

IAS 27 - Consolidated and Separate Financial Statements

 

IFRIC 11 - Group and Treasury Share Transactions

 

IFRS 3 - Business Combinations

 

IFRS 9 - Financial Instruments

 

2 Accounting policies

 

Basis of preparation of preliminary financial information

The financial statements, upon which this financial information is based, have been prepared using accounting policies consistent with International Financial Reporting Standards (IFRS).

 

This financial information does not constitute the Company's statutory accounts as defined in section 434 of the Companies Act 2006 and has been prepared on the basis of the accounting policies set out in the financial statements for the year ended 31 March 2010. Statutory accounts for 2009 have been delivered to the Registrar of Companies, and those for 2010 will be delivered in due course following the company's annual general meeting. The auditors have reported on the 2009 accounts and their report was unqualified, did not include references to any matters by way of emphasis without qualifying their report and did not contain statements under Section 237 (2) or (3) of the Companies Act 1985.

 

The Annual Report and Financial Statements will be posted to shareholders shortly and thereafter will be available from the Company's registered office, and from the Company's website www.samuel-heath.com.

 

The financial statements have been prepared under the historical cost basis except for the valuation of Available For Sale assets which have been revalued to market value.

 

 

3 Critical accounting and key sources of estimation

 

Critical judgements in applying the entity's accounting policies

 

In the process of applying the entity's accounting policies, which are described above, the directors have made the following judgements that have the most significant effect on the amounts recognised in the financial statements.

 

 

Income taxes

 

The Group is subject to income taxes in the United Kingdom. Judgment is required in determining the provision for income taxes. There are many transactions and calculations for which the ultimate tax determination is uncertain during the ordinary course of business. The Group recognises liabilities for anticipated tax audit issues based on estimates of whether additional taxes will be due. Where the final tax outcome of these matters is different from the amounts that were initially recorded, such differences will impact the income tax and deferred tax provisions in the period in which such determination is made.

 

The recoverable amounts of the Group's deferred tax assets have been determined based on the Board's estimates of future taxable profits and income and tax rates.

 

Key sources of estimation uncertainty

 

The key assumptions concerning the future, and other key sources of estimation uncertainty at the balance sheet date, that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year, are discussed below.

 

Retirement benefit scheme deficit

The valuation of expected returns on assets and the present value of the liabilities of the scheme are determined by assumptions and estimates made by the directors based on the current information to hand. Therefore amounts are open to fluctuations in the future due to unforeseen changes or additional factors that come to light following the year end.

 

4. Income taxes

 

 

2010

£000

2009

£000

Current taxes

112

(125)

Deferred taxes

(8)

102

Total income taxes

104

(23)

Corporation tax is calculated at 28% (2009: 28%) of the estimated assessable profit for the year.

Tax rate reconciliation

2010

£000

2009

£000

Profit for the year

336

292

Corporation tax charge thereon at 28% (2009: 28%)

94

82

Adjusted for the effects of:

Depreciation in excess of capital allowances

37

9

Marginal relief

(18)

(12)

Prior year adjustments

-

(37)

Research and development claim

(22)

(30)

Capitalisation of research and development expenditure

(31)

(46)

Loan relationships

29

6

Other adjustments

15

5

Total Income tax

104

(23)

Effective tax rate

31.0%

(7.9%)

5. Dividends

2010
2009

£ 000

£ 000

Final dividend for the year ended 31st March 2009 of 6.25 pence per share (2008: 12.5 pence per share)

158

317

Interim dividend for the year ended 31st March 2010 of 5.50 pence per share (2009: 11.0 pence per share)

140

279

298

596

 

In addition to the dividends paid during the year the directors are recommending a final dividend for 2010 of 6.25 pence per share amounting to £158,000. The proposed final dividend is subject to approval at the Annual General Meeting (see note 8) and has not been included as a liability in these accounts.

6. Earnings per share

The basic and diluted earnings per share are calculated by dividing the relevant profit after taxation of £232,000 (2009: £315,000) by the average number of ordinary shares in issue during the year being 2,534,322 (2009: 2,534,577). The number of shares used in the calculation is the same for both basic and diluted earnings.

 

 

7. Notes to the cash flow statement

 

2010  2009

£000

£000

Operating profit

405

243

Depreciation, amortisation and impairment

554

471

(Gain)/loss on disposal of property, plant and equipment

(3)

12

Operating cash flows before movements in working capital

956

726

Decrease in inventories

249

133

Decrease in receivables

102

413

Increase/(decrease) in payables

76

(133)

Pension contributions

(255)

(505)

Cash generated by operations

1,128

634

Income tax received/(paid)

88

(176)

Net cash flow from operating activities

1,216

458

 

Cash and cash equivalents (which are presented as a single class of assets on the face of the Statement of Financial Position) comprise cash at bank and other short-term highly liquid investments with a maturity of three months or less.

 

 

8. Annual General Meeting

 

The Annual General Meeting has been fixed for 20th August 2010 at 12 noon. The final Ordinary Share dividend of 6.25 pence, if approved, will be payable on 27th August 2010 to ordinary shareholders registered at close of business on 30th July 2010.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR SSIFIWFSSELW
Date   Source Headline
21st Nov 20237:00 amRNSHalf-year Report
7th Sep 20231:53 pmRNSResult of AGM
21st Jul 20237:00 amRNSFinal Results
9th Dec 20221:48 pmRNSHolding(s) in Company
9th Dec 20221:45 pmRNSDirector/PDMR Shareholding
18th Nov 20227:00 amRNSHalf-year Report
25th Aug 20223:08 pmRNSResult of AGM
20th Jul 202212:40 pmRNSReplacement: Final Results
20th Jul 20227:00 amRNSFinal Results
12th Nov 20217:00 amRNSHalf-year Report
6th Aug 20211:35 pmRNSResult of AGM
19th Jul 202110:14 amRNSDirectorate Change
8th Jul 20212:34 pmRNSFinal Results
30th Dec 20207:00 amRNSDirectorate Change
12th Nov 20207:00 amRNSHalf-year Report
7th Aug 20202:35 pmRNSResult of AGM
10th Jul 20207:30 amRNSFinal Results
9th Jul 20204:13 pmRNSHolding(s) in Company
8th Apr 20203:40 pmRNSCOVID-19 Trading Update
6th Feb 20207:00 amRNSDirectorate Change
18th Dec 20197:00 amRNSDirector/PDMR Shareholding
10th Dec 20199:53 amRNSDirectorate Change
15th Nov 20197:00 amRNSHalf-year Report
9th Aug 20192:45 pmRNSResult of AGM
15th Jul 20194:38 pmRNSHolding(s) in Company
11th Jul 20197:00 amRNSFinal Results
1st Apr 201911:47 amRNSPDMR/PCA Dealing
8th Nov 20187:00 amRNSHalf-year Report
10th Aug 20181:01 pmRNSResult of AGM
12th Jul 20183:26 pmRNSFinal Results
15th Jan 201811:13 amRNSDividend Record Date
9th Nov 20177:00 amRNSHalf-year Report
13th Oct 20179:45 amRNSHolding(s) in Company
13th Oct 20179:43 amRNSHolding(s) in Company
29th Sep 20177:00 amRNSDirectorate Change
1st Sep 20179:22 amRNSDirectorate Change
14th Aug 201711:48 amRNSResult of AGM
12th Jul 20179:33 amRNSFinal Results
16th Jun 20177:00 amRNSDirector/PDMR Shareholding - Replacement
10th May 20172:34 pmRNSDirector/PDMR Shareholding
7th Mar 20173:36 pmRNSDirector/PDMR Dealing
28th Feb 20177:00 amRNSDirectorate Change
16th Nov 20168:00 amRNSHalf-year Report
29th Sep 20163:59 pmRNSDirectorate Change
12th Aug 20161:26 pmRNSResult of AGM
11th Aug 201612:22 pmRNSDirectorate Change
13th Jul 20167:00 amRNSFinal Results
7th Jul 20162:32 pmRNSNotice of Results
6th May 20167:00 amRNSChange of Adviser
4th Nov 20157:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.